Prenatal gene editing success lays path for treating congenital diseases in the womb

Written by admin

In a remarkable proof-of-concept study, scientists from the University of Pennsylvania and the Children’s Hospital of Philadelphia have, for the first time, successfully used CRISPR gene-editing technology on mice in utero, to prevent the animals being born with a lethal metabolic disorder.

Let’s block ads! (Why?)

Source link

About the author


Leave a Comment